Aclarion (NASDAQ: ACON, ACONW) has announced that its Nociscan platform is now available at Goodman Campbell Brain & Spine at Ascension St. Vincent, marking the first site in Indiana to offer the technology.
Nociscan uses magnetic resonance spectroscopy to extract and quantify chemical biomarkers associated with disc pain. The objective, non-invasive insights provided by Nociscan enable physicians to distinguish between painful and nonpainful discs in the lumbar spine—information that MRI cannot provide.
In a statement, Brent Ness, CEO of Aclarion, commented, “Goodman Campbell’s reputation for clinical excellence and its role in training the next generation of neurosurgeons make them an important addition to the Nociscan network. The addition of each new site reflects the growing momentum behind Nociscan adoption as we work to bring this technology within reach of more patients living with chronic low back pain.”
